Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
CRISIS: 413.733.6661

Basic InformationMore InformationLatest News
Study Cites Factors Linked to Suicide in the YoungSelf-Harm Can Be a Harbinger of SuicideSuicide Often Leaves Mental, Physical Woes in Surviving SpouseDrinking, Drug Abuse Doubles Veterans' Suicide Risk: StudyU.S. Suicide Rates Rising Faster Outside CitiesSame-Sex Marriage Laws Tied to Fewer Teen SuicidesBrain Scans May Shed Light on Bipolar Disorder-Suicide RiskPilots Suffer Depression, Suicidal Thoughts at Fairly High RatesSubway Surveillance Video Provides Clues to Suicidal BehaviorSuicide Risk Up for Patients With Acute Coronary SyndromeDepression, Suicide Ideation Prevalent in Medical StudentsAttempted Suicide Rates in U.S. Remain UnchangedTeen 'Choking Game' Played Solo Points to Suicide RisksSuicide Can Strike Children as Young as 5: StudyNearly 10 Million U.S. Adults Considered Suicide Last YearKnow the Warning Signs of Suicidal ThoughtsSerious Infections Tied to Suicide RiskLocked Doors May Not Prevent Inpatient Suicide, AbscondingBinge-Eating Disorders May Be Linked to SuicidalityEuthanasia, Doc-Assisted Suicide Increasingly Being LegalizedDoctor-Assisted Deaths Didn't Soar After LegalizationJobs With the Highest Suicide RatesReligious Service Attendance May Lower Suicide Risk in WomenReligion a Buffer Against Suicide for Women, Study SuggestsAAP: Doctors Should Screen Teens for Suicide Risk Factors1 in 13 Young Adults in U.S. Considered Suicide in Past YearThe Childhood Incidents That Increase Later Suicide RiskStrategies That Work to Help Prevent SuicidesAmong U.S. Military, Army Members Face Highest Suicide RiskTough Economy, Alcohol Fuels Suicide Risk in Men: StudyPredeployment Riskiest Time for Military Suicide AttemptsStates With More Gun Owners Have More Gun-Related Suicides: StudyFamily Rejection Triples Risk for Suicide Attempts by Transgender People: StudyKetamine May Ease Suicidal Thoughts in Major DepressionCan the Anesthetic Ketamine Ease Suicidal Thoughts?Atomoxetine Use Doesn't Up Suicide Risk in ChildrenYoung Gay, Bisexual Men May Be at Higher Risk for Suicide, Study FindsTeen Boys Who Attempt Suicide More Likely to Abuse as AdultsNew National Suicide Statistics at a Glance
Questions and AnswersLinksBook Reviews
Related Topics

Bipolar Disorder
Depression: Depression & Related Conditions
Grief & Bereavement Issues
Death & Dying

Atomoxetine Use Doesn't Up Suicide Risk in Children

HealthDay News
Updated: Apr 27th 2016

new article illustration

WEDNESDAY, April 27, 2016 (HealthDay News) -- Treatment with the selective noradrenalin-reuptake-inhibitor atomoxetine is not associated with increased suicide risk compared with stimulant use in children and adolescents, according to a study published online April 26 in Pediatrics.

Stephan Linden, Ph.D., from the University of Florida in Gainesville, and colleagues examined the risk of suicide and suicide attempt in pediatric patients initiating treatment with atomoxetine versus stimulants in a retrospective cohort design study. The first- and second-line treatment cohorts included 279,315 and 220,215 patients, respectively.

The researchers found that in the first-line treatment cohort the adjusted hazard ratio for current atomoxetine use versus stimulant use was 0.95 during the first year of follow-up (95 percent confidence interval, 0.47 to 1.92; P = 0.88). The adjusted hazard ratio for current atomoxetine use versus stimulant use was 0.71 during the first year of follow-up in the second-line treatment cohort (95 percent confidence interval, 0.30 to 1.67; P = 0.43).

"First- and second-line treatment of youths age 5 to 18 with atomoxetine compared with stimulants was not significantly associated with an increased risk of suicidal events," the authors write. "The low incidence of suicide and suicide attempt resulted in wide confidence intervals and did not allow stratified analysis of high-risk groups or assessment of suicidal risk associated with long-term use of atomoxetine."

Two authors disclosed financial ties to the pharmaceutical industry.

Full Text (subscription or payment may be required)